3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
2
Breast Neoplasms
2
von Hippel-Lindau Disease
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Neoplasm Metastasis
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Liposarcoma
1
Leiomyosarcoma
1
Hormone Receptor Positive Breast Cancer
1
Hamartoma Syndrome, Multiple
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Bone Neoplasms
1
Autistic Disorder
1
Astrocytoma
1
Angiomyolipoma
1
Interventions
Nivolumab
21
pembrolizumab
18
Ipilimumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
7
trametinib
5
binimetinib
5
Opdualag
5
relatlimab
4
dabrafenib
4
atezolizumab
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
Biopsy
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
aldesleukin
2
X-Rays
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Everolimus
×
30 days
×
Clear all
No trials found.